Wed. 4 Sep 2024, 4:40pm ET
Benzinga
Biotech, News, FDA, General
MODD1 is a patch pump for ALL adults with Type 1 and Type 2 diabetes
Designed to be simpler and more affordable to expand access to diabetes technology for previously underserved communities
Commercial availability expected in early 2025